[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"body-contouring-surgery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:body-contouring-surgery":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,54],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100589789","effects-of-quantum-probe-for-skin-rejuvenation-and-subdermal-retraction-in-patients-undergoing-high-definition-liposculpture-100589789",false,"NCT06958978","Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture","Quantum001","Inclusion Criteria:\n\n* Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermolipectomy.\n* Healthy patients without underlying comorbidities (classified as ASA≤II)\n\nExclusion Criteria:\n\n* Pregnant patients, patients planning to get pregnant, or in breastfeeding stage\n* Past medical history of any collagen disease or autoimmune conditions, including lupus, scleroderma, connective tissue disorders, rheumatoid arthritis, or multiple sclerosis.\n* Past medical history of skin disease including active skin infections, dermatitis, or history of keloid formation.\n* Patient with any metal implants or pacemakers\n* BMI ≥ 32 kg\u002Fm2.",true,"ALL","18 Years","60 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","This prospective study aims to evaluate the safety and effectiveness of Quantum, a fully internal bipolar radiofrequency probe, for the treatment of prominent skin laxity, providing patients with a more toned and youthful appearance, in patients undergoing High-Definition (HD) Liposculpture.\n\nThe main questions this study seeks to answer are:\n\n* Does Quantum reduce skin laxity in patients undergoing HD Liposculpture?\n* Is the effectiveness in skin laxity reduction influenced by demographical factors, including age, gender, and phototype?\n\nThe participants will be adult patients (between 18-60 years) undergoing HD Liposculpture, with any measurable degree of skin laxity. The participants can not be pregnant, have history of scaring\u002Fhealing problems, autoimmune diseases, severe dermatological conditions, have metal implants, be obese, or have important comorbidities.",[28,29,30,31,32,33],"Skin Laxity","Skin Tightening","Body Contouring Surgery","Skin Elasticity","Skin Firmness","Liposuction",[35,36,37,38,33,39,40],"Quantum","Quantum RF","Elastometer","Body contouring","Liposculpture","High Definition Liposculpture","RECRUITING","2025-04-27",{"date":44,"type":45},"2025-05-06","ACTUAL",{"date":47,"type":45},"2024-02-01",{"date":49,"type":22},"2026-06",{"name":51,"class":52},"Total Definer Research Group","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":61,"enrollmentInfo":62,"targetDuration":4,"studyType":23,"phases":64,"briefSummary":66,"conditions":67,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":4},"100562338","phase-4-the-impact-of-nutritional-optimization-to-enhance-postoperative-outcomes-using-the-r-support-supplements-100562338","NCT06601868","The Impact of Nutritional Optimization to Enhance Postoperative Outcomes Using the R-Support Supplements","R-Support","Inclusion Criteria:\n\n* ASAI\\&II\n* Age 18-65\n* Type of surgery:\n\n  * Abdominoplasty o Breast reduction\n  * Breast reconstruction through a DIEaP-flap\n  * Extensive circumferential liposuction and body contouring surgery\n\nExclusion Criteria:\n\n* Patients with systemic illness, including:\n\n  * Diabetes\n  * Immune deficiencies\n  * Severe cardiovascular disease\n  * Renal insufficiency\n* Active smokers or smokers that didn't quit 4 weeks prior to surgery\n* Patients under chemotherapy (Patients currently undergoing chemotherapy are not allowed to participate in this study. Patient undergoing previous chemotherapy are allowed to participate in this study, as long as the chemotherapy ended 6 months before the planned surgery and are currently in remission or free of disease.)\n* Patients after bariatric surgery with partial or complete stomachresection\n* Patients taking SSRI medication\n* Pregnancy\n* ASAIII\\&IV\n* Gluten intolerance\n* Lactose intolerance\n* Allergy or hypersensitivity to fish, soya, milk, shellfish.","65 Years",{"count":63,"type":22},200,[65],"PHASE4","The aim of this pilot study is to evaluate the potential benefits of nutrient supplementation on post-operative recovery for patients undergoing certain types of surgery, compared to those who do not receive such supplementation. The multi-center study will be conducted in Belgium and the Netherlands at UZ Brussel, Delta CHIREC, and Zuyderland Medical Center.\n\nThe pilot study will serve as a precursor to a randomized controlled trial and will include 200 patients. Participants must be classified as ASA I or II, aged between 18 and 65, and undergoing abdominoplasty, breast reduction, breast reconstruction through a DIEP-flap, or extensive circumferential liposuction and body contouring surgery.\n\nEligible patients who provide informed consent will be randomly assigned to either the intervention group, receiving R-Support supplementation, or the control group, without supplementation. Each group will consist of 100 patients. The study will span 8 weeks, with a 2-week preoperative period and a 6-week postoperative period. The treatment will involve a 28-day supplementation period, with R-Support Recover Prepare given 14 days preoperatively and R-Support Recover After given 14 days postoperatively.\n\nPostoperative recovery will be assessed using the PRP-Questionnaire and Functional Recovery Index, which together will measure physical and psychological recovery, as well as the speed of recovery in the early postoperative phase. The study hypothesizes that the intervention group will experience quicker recovery than the control group. Additionally, data on hospital stay duration and early postoperative complications will be collected, with the expectation that better-prepared bodies will recover faster, potentially leading to fewer hospitalized days and complications. The study aims to demonstrate enhanced postoperative recovery, reduced early complications (such as wound dehiscence and infection), and shorter hospital stays.",[68,69,70,30],"Abdominoplasty","Breast Reduction","Autologous Breast Reconstruction","NOT_YET_RECRUITING","2024-09-18",{"date":74,"type":45},"2024-09-20",{"date":76,"type":22},"2024-10-01",{"date":78,"type":22},"2025-12-31",{"name":80,"class":52},"Universitair Ziekenhuis Brussel"]